Advertisement

Patterson hires Mark Walchirk, a McKesson executive, as its next CEO

The appointment ends an unexpected transition at the supplier of dental and animal health products.

October 25, 2017 at 1:06AM
Mark Walchirk, named president and CEO of Patterson Companies on Oct. 24, he will start Nov. 20th.
Walchirk was most recently at McKessen Corp.
Walchirk (The Minnesota Star Tribune)

Patterson Cos. on Tuesday named Mark Walchirk, a top executive at McKesson Corp., as its new president and chief executive.

Walchirk, 51, will succeed James Wiltz, who stepped in as interim chief of the dental and veterinary supplies business after the departure of Scott Anderson on June 1. Walchirk, who starts Nov. 20, also will join the board of directors.

"Patterson is a great company with a proud history and an extraordinary opportunity to leverage its position in its markets to deliver great service and solutions to customers and value to shareholders," Walchirk said in a company release. "I am honored and excited to help lead the team during this transformative time."

Walchirk was most recently president of the U.S. pharmaceutical unit of McKesson, the largest business of the San Francisco-based company. The business supplied branded, generic and over-the-counter drugs and related services to retail chains, pharmacies, hospitals, health systems and long-term care providers.

Walchirk joined McKesson in 2001 and rose through the executive ranks. Before that, he spent 13 years in medical distribution and manufacturing with Baxter Healthcare, Allegiance Healthcare and Encompass Group. He is a graduate of the University of Illinois.

"After a thorough search, we are pleased to have found such an exceptional leader and operator as Mark to lead Patterson going forward," said Patterson Chairman John Buck in a news release. "Mark has a proven track record of success in helping a large and complex market leader navigate through an evolving and dynamic environment to achieve growth."

Patterson, based in St. Paul, is a value-added distributor of dental and animal health products with annual revenue of $5.6 billion in its latest fiscal year, which ended in April. The animal health business accounts for 56 percent of total revenue.

Patterson earned $170.9 million in the previous year, but net income decreased 8.7 percent. Earnings have declined in five of the previous six years.

Advertisement
Advertisement

Walchirk will start with an annual salary of $850,000 a year and be eligible for other employee benefits. He will also receive a restricted stock award worth $2 million as a signing bonus and a lump sum cash bonus of $100,000.

He will also be eligible for annual cash and equity incentive awards, a prorated amount for the remainder of fiscal 2018, and more than $1 million in cash awards and $3 million in equity awards in the years after that.

Patrick Kennedy • 612-673-7926

about the writer

about the writer

Patrick Kennedy

Reporter

Business reporter Patrick Kennedy covers executive compensation and public companies. He has reported on the Minnesota business community for more than 25 years.

See Moreicon

More from Business

See More
This photo taken on May 12, 2014, shows beloved family pets memorialized with statues at the Los Angeles Pet Cemetery in Calabasas, Calif. Saying goodbye to a beloved dog or cat is hard. Despite many options, an estimated 70 percent of owners will leave the body with their veterinarian to dispose of.

Emotional and financial considerations range from euthanasia timing, cremation decisions and how to best memorialize a furry friend.

card image
573499807
Advertisement
Advertisement

To leave a comment, .

Advertisement